NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

American Campus Comm

(ACC) - Get Report

upgraded at UBS to Buy from Neutral, UBS said. $49 price target. Attractive risk/reward profile.

Air Products

(APD) - Get Report

downgraded at Keybanc from Buy to Hold, Keybanc said. Company is looking at lower earnings and lacks near-term catalysts.

Approach Resources

(AREX) - Get Report

downgraded to hold at TheStreet Ratings.

Avista

(AVA) - Get Report

downgraded at BMO from Market Perform to Underperform, BMO Capital said. $24 price target. Estimates also cut, given the company's new guidance.

Check Point

(CHKP) - Get Report

upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $52 price target. Stock is down 32% from its highs and the company has multiple potential drivers.

Celestica

(CLS) - Get Report

downgraded at Canaccord to Hold, Canaccord Genuity said. $8 price target. Company is seeing weaker demand and has low visibility.

CTC Media

(CTCM)

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $9.30 price target. Valuation call, as the stock is up 20% over the past three months.

Donaldson

(DCI) - Get Report

downgraded at Jefferies to Hold from Buy, Jefferies said. $33 price target. Multiple at risk.

DuPont

(DD) - Get Report

downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $47 price target.

Dollar Tree

(DLTR) - Get Report

upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Company was also placed on the Conviction List. $48 price target. Stock is down 31% in four months and near-term results should be strong.

Facebook

(FB) - Get Report

upgraded at Stifel from Hold to Buy, Stifel Nicolaus said. $26 price target. Company is shifting its business to mobile.

Facebook downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. $31 price target. Company can grow as it transitions to mobile.

Facebook upgraded at Citigroup to Buy from Neutral, Citigroup said. $30 price target. Strong Q3 results.

First Capital Bancorp

(FCVA)

upgraded to hold at TheStreet Ratings.

Iberiabank

(IBKC) - Get Report

upgraded at Wunderlich from Hold to Buy, Wunderlich said. Company is posting solid loan and deposit growth.

Iberiabank upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $52 price target. Company is seeing higher margins across the board.

Molycorp

(MCP)

upgraded at Dahlman from Hold to Buy, Dahlman Rose said. $14 price target. Mountain Pass should deliver a large production ramp.

Myriad Genetics

(MYGN) - Get Report

upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $32 price target. Company can continue to diversify and expand its business.

United Therapeutics

(UTHR) - Get Report

downgraded at JP Morgan from Neutral to Underweight, JP Morgan said. $40 price target. Oral Remodulin received a negative ruling from the FDA.

United Therapeutics downgraded at BMO from Outperform to Market Perform, BMO Capital said. $50 price target. New uncertainty around oral treprostinil.

Whirlpool

(WHR) - Get Report

upgraded at Goldman from Sell to Buy, Goldman Sachs said. $110 price target. Prices have firmed in Latin America.

STOCK COMMENTS / EPS CHANGES

Apple

(AAPL) - Get Report

estimates, target raised at Canaccord. Shares of AAPL now seen reaching $800, according to Canaccord Genuity said. Estimates also increased, given the new product launches. Buy rating.

Altera

(ALTR) - Get Report

estimates, target reduced at BMO. ALTR estimates were cut through 2013, BMO Capital said. Company is seeing lower sales. Outperform rating and new $38 price target.

Amgen

(AMGN) - Get Report

estimates, target increased at BMO. AMGN estimates were raised through 2013, BMO Capital said. Company is cutting costs and buying back more stock. Market Perform rating and new $83 price target.

Activision Blizzard

(ATVI) - Get Report

added to US Focus List at Credit Suisse. Company can expand its margins over the coming quarters.

Broadcom

(BRCM)

estimates, target cut at Credit Suisse. Shares of BRCM now seen reaching $45, according to Credit Suisse. Estimates also reduced, as the company is seeing lower sales. Outperform rating.

Centene

(CNC) - Get Report

numbers raised at Oppenheimer. Shares of CNC now seen reaching $48, Oppenheimer said. Estimates also raised on third quarter earnings. Outperform rating.

Coach

(COH)

numbers raised at UBS. Shares of COH now seen reaching $58, UBS said. Estimates also increased as F1Q trends improve. Neutral rating.

DuPont

(DD) - Get Report

numbers cut at UBS. Shares of DD now seen reaching $52, UBS said. Estimates also lowered on material 3Q EPS miss. Neutral rating.

Gilead

(GILD) - Get Report

estimates, target boosted at Credit Suisse. Shares of GILD now seen reaching $65, according to Credit Suisse. Estimates also upped, given higher product sales. Neutral rating.

Gilead Sciences numbers raised at Jefferies. Shares of GILD now seen reaching $59, Jefferies said. Estimates also raised on HCV pipeline. Hold rating.

Hartford Financial

(HIG) - Get Report

added to US Focus List at Credit Suisse. HIG was added to the US focus list, according to Credit Suisse. See upside to capital return expectations.

Kansas City Southern

(KSU) - Get Report

added to US Focus List at Credit Suisse. KSU was placed on the US focus list, Credit Suisse said. Company can continue to grow faster than consensus expectations.

3M

(MMM) - Get Report

estimates trimmed at UBS through 2013, UBS said. 3Q outlook weaker than expected. Buy rating and $100 price target.

Netflix

(NFLX) - Get Report

numbers lowered at Oppenheimer. Shares of NFLX now seen reaching $80, Oppenheimer said. Estimates also lowered on weak subs and guidance. Outperform rating.

Netflix estimates, target cut at BofA/Merrill. Shares of NFLX now seen reaching $60, according to Bank of America/Merrill Lynch said. International segment will likely continue to lose money for the next few years. Underperform rating.

Netflix target cut at Citigroup. NFLX target lowered to $100, Citigroup said. Q3 miss, but willing to look through forecasting errors. Buy rating.

Norfolk Southern

(NSC) - Get Report

numbers lowered at Sterne Agee. Shares of NSC now seen reaching $81, according to Sterne Agee. Estimates also cut, given a reduced coal outlook. Buy rating.

Travelers

(TRV) - Get Report

estimates, target increased at Sterne Agee. TRV estimates were raised through 2014, Sterne Agee said. Company is seeing a higher reserve release and lower loss ratio. Neutral rating and new $77 price target.

VMWare

(VMW) - Get Report

estimates, target raised at BMO. Shares of VMW now seen reaching $100, according to BMO Capital. Estimates also increased, as the company is cutting costs. Market Perform rating.

Whirlpool

(WHR) - Get Report

estimates, target upped at JP Morgan. WHR estimates were boosted through 2013, JP Morgan said. Company is seeing higher growth in North America. Neutral rating and new $95 price target.

Xerox

(XRX) - Get Report

estimates, target reduced at BMO.Shares of XRX now seen reaching $8, according to BMO Capital. Estimates also cut, as the company is realizing lower margins. Market Perform rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Get Ready for the Bank Stock Apocalypse

>>Apple iPad Mini: First Impressions

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.